Sea Crest Wealth Management, LLC Corcept Therapeutics Inc Transaction History

Sea Crest Wealth Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Jul 19, 2019	SELL	$9.78 - $12.76 $9,780 - $12,760	-1,000 Closed	0 $0
Q1 2019 May 10, 2019	SELL	$10.03 - $15.71 $5,015 - $7,855	-500 Reduced 33.33%	1,000 $12,000
Q4 2018 Feb 13, 2019	SELL	$11.29 - $17.19 $58,143 - $88,528	-5,150 Reduced 77.44%	1,500 $20,000
Q3 2018 Nov 14, 2018	SELL	$12.27 - $15.65 $65,031 - $82,945	-5,300 Reduced 44.35%	6,650 $93,000
Q2 2018 Aug 03, 2018	SELL	$15.3 - $19.69 $96,390 - $124,047	-6,300 Reduced 34.52%	11,950 $188,000
Q1 2018 Apr 20, 2018	SELL	$14.59 - $25.5 $35,016 - $61,200	-2,400 Reduced 11.62%	18,250 $300,000
Q4 2017 Feb 02, 2018	BUY	$15.77 - $20.72 $325,650 - $427,868	20,650	20,650 $373,000

347

86.6M

1.12M

667K

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $6.43B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

Get notified when there are updates to the investment portfolio of Sea Crest Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sea Crest Wealth Management, LLC with notifications on news.